Epidemiology, Clinical Presentation and Treatment of Non-Hepatic Hyperammonemia in ICU COVID-19 Patients

(1) Background: Although COVID-19 is largely a respiratory disease, it is actually a systemic disease that has a wide range of effects that are not yet fully known. The aim of this study was to determine the incidence, predictors and outcome of non-hepatic hyperammonemia (NHH) in COVID-19 in intensi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nardi Tetaj, Giulia Valeria Stazi, Maria Cristina Marini, Gabriele Garotto, Donatella Busso, Silvana Scarcia, Ilaria Caravella, Manuela Macchione, Giada De Angelis, Rachele Di Lorenzo, Alessandro Carucci, Alessandro Capone, Andrea Antinori, Fabrizio Palmieri, Gianpiero D’Offizi, Fabrizio Taglietti, Stefania Ianniello, Paolo Campioni, Francesco Vaia, Emanuele Nicastri, Enrico Girardi, Luisa Marchioni, on behalf of ICU COVID-19 Study Group
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2022-05-01
Col·lecció:Journal of Clinical Medicine
Matèries:
COVID-19
Coronavirus disease
intensive care unit
non-hepatic hyperammonemia
Accés en línia:https://www.mdpi.com/2077-0383/11/9/2592
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars